Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Lifson

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Journal of Virology|September 11, 1999
Protection by live, attenuated simian immunodeficiency virus against heterologous challengeM S Wyand, K Manson, D C Montefiori, et al.
Journal of Virology|October 10, 1998
CD4(+) T-lymphocyte depletion in human lymphoid tissue ex vivo is not induced by noninfectious human immunodeficiency virus type 1 virionsA W Sylwester, J C Grivel, W Fitzgerald, et al.
American Journal of Clinical Pathology|December 1, 1986
The immunohistology of the persistent generalized lymphadenopathy syndrome (PGL)C F Garcia, J D Lifson, E G Engleman, et al.
Cell|June 5, 1987
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneB S Stein, S D Gowda, J D Lifson, et al.
Biochemical Pharmacology|April 15, 1992
CD4(81-92)-based peptide derivatives. Structural requirements for blockade of HIV infection, blockade of HIV-induced syncytium formation, and virostatic activity in vitroD M Rausch, J D Lifson, M P Padgett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formationV S Kalyanaraman, D M Rausch, J Osborne, et al.
Science (New York, N.Y.)|August 5, 1988
Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicityJ D Lifson, K M Hwang, P L Nara, et al.
Journal of Virology|October 24, 2000
Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with timeP S Silverstein, G A Mackay, S Mukherjee, et al.
Journal of Virology|January 11, 2001
Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1M T Esser, J W Bess, K Suryanarayana, et al.
Clinical Immunology and Immunopathology|November 1, 1992
Human immunodeficiency virus-infected monocyte-derived macrophages express surface gp120 and fuse with CD4 lymphoid cells in vitro: a possible mechanism of T lymphocyte depletion in vivoS M Crowe, J Mills, T Elbeik, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Journal of Virology|September 11, 1999
Protection by live, attenuated simian immunodeficiency virus against heterologous challengeM S Wyand, K Manson, D C Montefiori, et al.
Journal of Virology|October 10, 1998
CD4(+) T-lymphocyte depletion in human lymphoid tissue ex vivo is not induced by noninfectious human immunodeficiency virus type 1 virionsA W Sylwester, J C Grivel, W Fitzgerald, et al.
American Journal of Clinical Pathology|December 1, 1986
The immunohistology of the persistent generalized lymphadenopathy syndrome (PGL)C F Garcia, J D Lifson, E G Engleman, et al.
Cell|June 5, 1987
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneB S Stein, S D Gowda, J D Lifson, et al.
Biochemical Pharmacology|April 15, 1992
CD4(81-92)-based peptide derivatives. Structural requirements for blockade of HIV infection, blockade of HIV-induced syncytium formation, and virostatic activity in vitroD M Rausch, J D Lifson, M P Padgett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formationV S Kalyanaraman, D M Rausch, J Osborne, et al.
Science (New York, N.Y.)|August 5, 1988
Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicityJ D Lifson, K M Hwang, P L Nara, et al.
Journal of Virology|October 24, 2000
Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with timeP S Silverstein, G A Mackay, S Mukherjee, et al.
Journal of Virology|January 11, 2001
Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1M T Esser, J W Bess, K Suryanarayana, et al.
Clinical Immunology and Immunopathology|November 1, 1992
Human immunodeficiency virus-infected monocyte-derived macrophages express surface gp120 and fuse with CD4 lymphoid cells in vitro: a possible mechanism of T lymphocyte depletion in vivoS M Crowe, J Mills, T Elbeik, et al.
Pageof 9